ENO2 and Alzheimer disease: Increased NSE levels are associated with oxidative damage as a diagnostic marker in numerous neurodegenerative diseases such as Huntington's disease, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis22–25.